Loading…
ANVS
Annovis Bio, Inc.
NYSE· Healthcare· Biotechnology· CUSIP 03615A108
$0.99-5.39%Price as of Oct 17, 12:05 UTC · updated once a day, after the close
At a glance
Annovis Bio, Inc. (ANVS) is listed on NYSE and classified in Biotechnology, part of the Healthcare sector. It is headquartered in Malvern, United States and has 7 employees. The company is worth $42.4M. Revenue was $0 in fiscal 2025. It reported a net loss of $28.85M. The share price is 81.9% below its 52-week high of $5.50. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Renaissance Technologies, at $1.86M. In that quarter, 1 of them opened or added to the position. No open-market insider trades in it were filed over the last 30 days.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $42.4M
- P/E
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- -$1.75
- ROE
- -703.68%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- 1.23
- 52-week high
- $5.50
- 52-week low
- $0.99
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -95.9% over 5Y.
today you would have $37.46▼ -96.3%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $3.46 | $5.03 | $18.70 | $13.43 | |
| P/B | 5.6x | 5.6x | 7.6x | — | 3.9x |
| EPS | -$1.40 | -$2.31 | -$6.23 | -$3.10 | |
| ROE | -171.23% | -171.23% | -264.20% | — | -89.43% |
Median of the years shown; P/E years above 200x are left out.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ELTXElicio Therapeutics, Inc. | $1.56 | — | 4.3x | 0.00% | -774.56% | $42.26M |
| SNWVSANUWAVE Health, Inc. | $4.96 | 20.7x | 15.3x | 0.00% | — | $42.67M |
| ACETAdicet Bio, Inc. | $4.57 | — | 0.4x | 0.00% | -78.08% | $42.78M |
| DWTXDogwood Therapeutics, Inc. | $1.22 |
About the company
- 7
- Malvern, United States